Down 5%: Here's why the Collection House Ltd share price is falling

The Collection House Ltd (ASX:CLH) share price fell 5% following the release of its half-year profit report.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Collection House Ltd (ASX: CLH) share price fell 5% today, following the release of its half-year profit report.

Here are the key takeaways from the debt collectors half-year to 31 December 2016:

  • Net profit fell 2% to $8.2 million
  • Revenue rose 2% to $66 million
  • A fully franked dividend of 3.9 cents per share was declared
  • Contracted Purchased Debt Ledger (PDL) acquisitions totalled $52.1 million

Collection House shares fell 10% in the month leading into today's announcement, however, the result does not appear that bad.

The company's Collection Services business reported strong revenue growth and flat profits. The division recently on-boarded Cash Converters International Ltd (ASX: CCV) as a client and won the contract for Transurban Group (ASX: TCL).

The PDL segment saw lower interest income. Collection House said the market remains competitive but it is showing signs of easing.

Looking ahead, the company expects to report profit between $19.4 million and $20 million over the full year. That would put its shares on a price-earnings ratio of around 8.5 times and a dividend yield of 6.3% fully franked if it declares a 3.9 cents per share dividend in the second half.

Should you buy Collection House?

Today's profit result, while lower than that from the same period last year, appears decent. Until recently, I think Collection House was run only to profit its management in the short-term.

Right now, the company's shares look cheap and potentially offer a handy dividend yield. However, I'm going to watch this one from the sidelines for a little while longer.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes and encourages your feedback. You can follow him on Twitter @OwenRask. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »